Surrozen

Surrozen is a biopharmaceutical company focused on the discovery and development of drugs that promote human tissue repair and regeneration. The company is currently preparing to establish a technology platform for developing multiple drugs by tapping into the medical potential of the Wnt signaling pathway. The Wnt signaling pathway plays a central role in animal development, maintaining stem cell pluripotency, and tissue regeneration. By selectively activating the Wnt pathway with targeted antibodies, Surrozen has pioneered new therapies to treat serious diseases characterized by tissue damage.